Skip to content

Management of Multisystem Inflammatory Syndrome in Children (MIS-C)

This activity is intended for hospital-based pharmacists focused on the identification and treatment of Multisystem Inflammatory Syndrome in children (MIS-C).

An understanding of multisystem inflammatory syndrome in children (MIS-C) is still evolving as we learn more about the pathophysiology of the disease. This presentation reviews the pathophysiology of MIS-C and demonstrates the temporal relationship between COVID-19 infection rates and rates of MIS-C cases. The most updated literature and guidance from the American College of Rheumatology and American Academy of Pediatrics on the management of MIS-C will be reviewed. Though the incidence of MIS-C is low compared to other pediatric conditions/syndromes, it is one that requires urgent attention in the context of the recent COVID-19 pandemic.

Learning Objectives

Upon completion of this activity, the participant should be able to:

  • Describe the definition and clinical presentation of MIS-C
  • Identify the pathophysiology of MIS-C
  • Discuss the role of steroids and immunomodulators in the management of MIS-C

Presenter

Barbara Luciano Damas, PharmD is a PGY1 Resident at Baystate Medical Center in Springfield, Massachusetts. She received her PharmD from MCPHS University Worcester campus in 2020. Her journey into the profession started, by chance, in 2010 when she took a job at Eaton Apothecary and developed a passion for pharmacy. Barbara is originally from Minas Gerais, Brazil but grew up in Framingham MA.

Fee is $12.00.

Register


ACPE logo

Release Date: June 10, 2021
Expiration Date: June 10, 2022
Contact Hours: 1 (.10 CEU)
Universal Activity Number: 0026-0000-21-135-H01-P| Knowledge-based
ACPE Topic Designator: Drug Therapy

Accreditation

Massachusetts College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Massachusetts College of Pharmacy and Health Sciences designates this educational activity for a total of 1 contact hours (0.1 CEUs).

Requirements for Credit

In order to receive credit, the participant must view the entire presentation and complete the pre and post-test, and evaluation. Upon completion participant credit will be reported to CPE Monitor. Transcripts may be printed from CPE Monitor.

Statement of Disclosure

It is the policy of MCPHS-CE to ensure balance, independence, objectivity and scientific rigor in all of its educational activities. All individuals engaged in the planning of a continuing education activity and who are in a position to control the educational content are required to disclose any financial relationships with ineligible companies occurring within the past 24 months. The intent of this policy is to identify and mitigate any potential conflict of interest that may directly or indirectly affect the activity. All recommendations involving clinical medicine must be based on evidence accepted within the medical profession.

MCPHS will identify, review and mitigate all conflicts of interest that speakers, authors or planners disclose prior to an educational activity being delivered to learners. Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation.

No funding from industry provided for this event. No exhibitors will be present.
Barbara Damas and MCPHS CE staff members hold no financial relationships with ineligible companies, related to the content of this presentation.